ATXS Dividend: Astria Therapeutics Inc Yield Insights

Income

Balance sheet

Cash flow

Annual

Quarterly

ATXS Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	39	34	25	19	14	11
Research & Development	98	77	42	34	180	25
Operating Expenses	137	111	67	53	194	37
Other Non Operating Income (Expenses)	0	0	0	0	0	0
Pretax Income	-124	-94	-72	-51	-194	-37
Income Tax Expense	--	--	--	--	--	--
Net Income	-124	-94	-72	-51	-219	-37
Net Income Growth	24%	31%	41%	-77%	492%	42%
Shares Outstanding (Diluted)	58	56.16	30.12	14.62	8.93	3.06
Shares Change (YoY)	0%	86%	106%	64%	192%	64%
EPS (Diluted)	-2.13	-1.67	-2.41	-3.55	-24.58	-12.19
EPS Growth	24%	-31%	-32%	-86%	102%	-13%
Free Cash Flow	-120	-81	-68	-43	-30	-32
Free Cash Flow Per Share	-2.06	-1.44	-2.25	-2.94	-3.35	-10.45
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	0%	0%	0%	0%
Profit Margin	0%	0%	0%	0%	0%	0%
Free Cash Flow Margin	0%	0%	0%	0%	0%	0%
EBITDA	--	--	--	--	--	--
EBITDA Margin	--	--	--	--	--	--
D&A For EBITDA	--	--	--	--	--	--
EBIT	-136	-111	-67	-53	-194	-37
EBIT Margin	0%	0%	0%	0%	0%	0%
Effective Tax Rate	--	--	--	--	--	--